ClinicalTrials.gg

Nobelpharma clinical trials

Part of Hisanaga & Co., Ltd., which holds 73.9% as of 2025-12-31. Source

The registry lists 34 studies whose lead sponsor is Nobelpharma. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 17, 2025.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

What it is testing

The drugs Nobelpharma’s studies test, most studies first; none is open now — 14 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 4 more

All 34 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed3191%
  • Stopped early39%

Phase

  • Phase 325
  • Phase 27
  • Phase 16

Where

  • Japan21
  • United States2

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 515
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 026

By the year each study started; 4 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Nobelpharma.

  • Nobelpharma
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    34 studies

Studies

Recruiting first, then most recently updated. Showing 34 of 34.